×
Avantor Cash on Hand 2018-2024 | AVTR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Avantor cash on hand for the quarter ending December 31, 2024 was
$0.262B
, a
0.38% decline
year-over-year.
Avantor cash on hand for 2024 was
$0.262B
, a
0.38% decline
from 2023.
Avantor cash on hand for 2023 was
$0.263B
, a
29.5% decline
from 2022.
Avantor cash on hand for 2022 was
$0.373B
, a
23.6% increase
from 2021.
View More
Avantor Cash on Hand 2018-2024 | AVTR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Avantor cash on hand for 2024 was
$0.262B
, a
0.38% decline
from 2023.
Avantor cash on hand for 2023 was
$0.263B
, a
29.5% decline
from 2022.
Avantor cash on hand for 2022 was
$0.373B
, a
23.6% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$148.1B
Elevance Health (ELV)
$90.8B
CVS Health (CVS)
$83.7B
Cencora (COR)
$47.6B
DiDi Global (DIDIY)
$23.1B
Natera (NTRA)
$22.8B
ICON (ICLR)
$15.8B
Doximity (DOCS)
$14.3B
BioMerieux (BMXMF)
$14.1B
Revvity (RVTY)
$14B
Viatris (VTRS)
$13B
Solventum (SOLV)
$12.8B
CochLear (CHEOY)
$11.5B
Medpace Holdings (MEDP)
$10.5B
HealthEquity (HQY)
$9.9B
EUROFINS SCIENT (ERFSF)
$9.5B
Sonic Healthcare (SKHHY)
$8.8B
Charles River Laboratories (CRL)
$8.4B
Amplifon S.p.A (AMFPF)
$6.2B
Bausch + Lomb (BLCO)
$5.7B
Organon (OGN)
$3.9B
Sotera Health (SHC)
$3.9B
BrightSpring Health Services (BTSG)
$3.6B
Surgery Partners (SGRY)
$3.3B
GeneDx Holdings (WGS)
$3.1B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$2.7B
Teladoc Health (TDOC)
$2.4B
Ardent Health Partners (ARDT)
$2.1B
Progyny (PGNY)
$2B